OCT and OCT-A Afer Diabetic Vitrectomy in PDR
Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05938491
Collaborator
(none)
30
17.1
Study Details
Study Description
Brief Summary
Detection of any structural or vascular changes at the macula after Pars Plana Vitrectomy ( PPV ) in cases with complicated proliferative diabetic retinopathy ( PDR )
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
OCT and OCT Angiography After Diabetic Vitrectomy With or Without Internal Limiting Membrane Peeling for Patients With PDR
Anticipated Study Start Date
:
Aug 1, 2023
Anticipated Primary Completion Date
:
Aug 1, 2024
Anticipated Study Completion Date
:
Jan 1, 2025
Outcome Measures
Primary Outcome Measures
- OCT and OCT angiography to assess the macular thickness , outline and vascularity [3 months after surgery]
Detection of any structural or vascular changes at the macula after Pars Plana Vitrectomy ( PPV ) in cases with complicated proliferative diabetic retinopathy ( PDR ) .
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Cases with complicated PDR as persistant vitreous hemorrhage or tractional retinal detachment involving or threatening the macula underwent PPV with or without ILM peeling
Exclusion Criteria:
- eyes with media opacity after PPV not allowing imaging of the macula
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Omar Abdelkarem Hasan,
Assistant lecturer of ophthalmology,
Assiut University
ClinicalTrials.gov Identifier:
NCT05938491
Other Study ID Numbers:
- oct after diabetic vitrectomy
First Posted:
Jul 10, 2023
Last Update Posted:
Jul 10, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: